Research & Clinical Trials

• 

  Research & Clinical Trials

  Phase III Trial of Durvalumab for Mesothelioma Underway

  The U.S. Food and Drug Administration will be closely watching the latest, international phase III clinical trial for unresectable pleural mesothelioma involving the…

  

  Tim Povtak

  April 1, 2021
• 

  Research & Clinical Trials

  Some Mesothelioma Patients May Benefit from Second Radical Surgery

  As overwhelming as major surgery for malignant pleural mesothelioma can be, there is a small cohort of patients who still would benefit from…

  

  Tim Povtak

  March 17, 2021
• 

  Research & Clinical Trials

  New Link Between Women with Mesothelioma and Survival Genes

  Men with mesothelioma outnumber women four to one. However, numerous studies have shown that women with mesothelioma often have a survival advantage…

  

  Sean Marchese, MS, RN

  March 10, 2021
• 

  Research & Clinical Trials

  Study: Which Mesothelioma Patients Will Immunotherapy Benefit?

  Thoracic surgeon Dr. Bryan Burt at the Baylor College of Medicine wants to better identify which patients with pleural mesothelioma cancer will benefit (and…

  

  Tim Povtak

  February 23, 2021
• 

  Research & Clinical Trials

  FDA Fast-Tracks Mesothelioma Vaccine Development

  The U.S. Food and Drug Administration has granted Fast-Track Designation this week to ONCOS-102, an immunotherapy vaccine that targets malignant mesothelioma and other hard-to-treat tumors.

  

  Tim Povtak

  February 19, 2021
• 

  Research & Clinical Trials

  Research Reinforces Gene Mutation Links to Mesothelioma

  More than ever, Dr. Michele Carbone at the University of Hawaii Cancer Center believes early testing for genetic mutations can lead to fewer cases…

  

  Tim Povtak

  February 11, 2021
• 

  Research & Clinical Trials

  Opdivo Study Offers Hope to Relapsed Mesothelioma Patients

  A recent study out of the United Kingdom finds patients with relapsed malignant mesothelioma can be treated effectively with single-agent nivolumab, safely improving overall and…

  

  Tim Povtak

  February 4, 2021
• 

  Research & Clinical Trials

  Researchers: Mesothelioma Trials Need More Inclusive Criteria

  Clinical trials for mesothelioma need more inclusive criteria to better reflect the patients being seen at major cancer treatment centers, according to a recent study…

  

  Tim Povtak

  February 2, 2021
• 

  Research & Clinical Trials

  Study: Mesothelioma Survival Rates Rise with SMART Protocol

  Using accelerated high-dose radiation prior to surgery produced an unprecedented 65.9-month median survival for a cohort of pleural mesothelioma patients who were part of a…

  

  Tim Povtak

  January 21, 2021
• 

  Research & Clinical Trials

  Statins May Give Boost to Mesothelioma Immunotherapy Drugs

  Researchers in Europe may have found the key to making immunotherapy drugs such as Opdivo and Keytruda more effective for a larger percentage of…

  

  Tim Povtak

  January 7, 2021